Abeona Therapeutics Inc.ABEONASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-2.5%
5Y CAGR-2.3%
Year-over-Year Change
Research and development spending
3Y CAGR
-2.5%/yr
vs -7.0%/yr prior
5Y CAGR
-2.3%/yr
Consistent
Acceleration
+4.4pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $26.81M | -22.0% |
| 2024 | $34.36M | +10.5% |
| 2023 | $31.09M | +7.3% |
| 2022 | $28.96M | -25.2% |
| 2021 | $38.73M | +28.5% |
| 2020 | $30.14M | -43.9% |
| 2019 | $53.77M | +38.9% |
| 2018 | $38.70M | +127.8% |
| 2017 | $16.99M | +59.4% |
| 2016 | $10.65M | - |